What is the ticker symbol for Verona Pharma?

Verona Pharma trades under the ticker VRNA on NASDAQ.

What sector does Verona Pharma operate in?

Verona Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VRNA in a portfolio?

PortView shows VRNA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Verona Pharma (VRNA) Stock Analysis

NASDAQHealthcareBiotechnology

$106.91+0.11%

1-year price historyRange $30.81 – $106.91

52-week range$106.91

$31.09$106.93

What Verona Pharma does

Verona Pharma plc is a biopharmaceutical company currently in its clinical development phase, focusing on the research, development, and eventual market launch of new therapies for respiratory illnesses where current treatments are inadequate. Its primary experimental medication is ensifentrine, an inhaled compound designed to simultaneously block both phosphodiesterase (PDE) 3 and PDE4 enzymes. This unique mechanism allows it to function both as a bronchodilator, helping to open the airways, and as an anti-inflammatory agent within a single drug. Ensifentrine is presently undergoing advanced (Phase 3) clinical trials to evaluate its effectiveness in treating chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. To provide versatile administration options, the company is developing ensifentrine in three distinct formulations: a nebulizer solution, a dry powder inhaler (DPI), and a pressurized metered-dose inhaler (pMDI). Verona Pharma plc was established in 2005 and conducts its operations from its headquarters in London, United Kingdom.

Key metrics

Market cap

$72.68B

P/E (TTM)

-102.80

EPS (TTM)

$-1.04

Beta

0.05

Dividend yield

0.00%

Revenue / share

$1.57

50-day avg

$105.93

200-day avg

$78.66

52-week high

$106.93

52-week low

$31.09

CEO

David S. Zaccardelli

ETFs linked to VRNA

Broad-market and Healthcare sector ETFs an investor holding Verona Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how VRNA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze VRNA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Verona Pharma?: Verona Pharma trades under the ticker VRNA on NASDAQ.
Which exchange is VRNA listed on?: VRNA is listed on NASDAQ.
What sector does Verona Pharma operate in?: Verona Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze VRNA in a portfolio?: PortView shows VRNA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.